Beam Therapeutics

In News

Beam Therapeutics (BEAM): Reassessing Valuation After New BEACON Sickle Cell Trial Results and Renewed Momentum - Yahoo Finance

Yahoo Finance - Dec 07, 2025

Beam Therapeutics (BEAM) Reveals Positive Trial Results at Hemat - GuruFocus

GuruFocus - Dec 07, 2025

Beam Therapeutics (BEAM): Valuation Check After Analyst Upgrades on Sickle Cell and Manufacturing Progress - simplywall.st

simplywall.st - Dec 05, 2025

Beam Therapeutics Reports Updated Data from BEACON Phase - GlobeNewswire

GlobeNewswire - Dec 06, 2025

Beam Therapeutics: Strong Buy On BEAM-101 Progress And In Vivo LNP Shots On Goal - Seeking Alpha

Seeking Alpha - Dec 04, 2025

Beam Therapeutics stock surges 64% since InvestingPro’s April undervalued call By Investing.com - Investing.com

Investing.com - Dec 05, 2025

Beam Therapeutics (BEAM) Strengthens Cash Position as Key Trials Move Forward - Insider Monkey

Insider Monkey - Nov 18, 2025

Beam Therapeutics (NASDAQ:BEAM) Stock Price Up 6.8% - What's Next? - MarketBeat

MarketBeat - Dec 04, 2025

Beam Therapeutics Stock Soars on Bullish Analyst Views - TipRanks

TipRanks - Dec 03, 2025

Stocks Generating Improved Relative Strength: Beam Therapeutics - Investor's Business Daily

Investor's Business Daily - Nov 18, 2025

Beam Therapeutics (BEAM) Is Up 6.8% After Analyst Optimism Around Sickle Cell Base-Editing Progress - What's Changed - simplywall.st

simplywall.st - Dec 04, 2025

Beam Therapeutics (BEAM) Experiences Significant Stock Surge - GuruFocus

GuruFocus - Dec 03, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment